e-learning
resources
Vienna 2009
Sunday, 13.09.2009
Cystic fibrosis: understanding a complex disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Metabolomic analysis by nuclear magnetic resonance spectroscopy of exhaled breath condensate in patients with cystic fibrosis
P. Montuschi, D. Paris, D. Melck, V. Lucidi, A. Motta (Rome, Pozzuoli (Naples), Italy)
Source:
Annual Congress 2009 - Cystic fibrosis: understanding a complex disease
Session:
Cystic fibrosis: understanding a complex disease
Session type:
E-Communication Session
Number:
480
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
P. Montuschi, D. Paris, D. Melck, V. Lucidi, A. Motta (Rome, Pozzuoli (Naples), Italy). Metabolomic analysis by nuclear magnetic resonance spectroscopy of exhaled breath condensate in patients with cystic fibrosis. Eur Respir J 2009; 34: Suppl. 53, 480
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Cystic fibrosis and intestinal organoids
Clinics of Cystic Fibrosis Patients with Unusual Bacteria Isolated fromRespiratory Cultures
Novel therapeutics for cystic fibrosis
Related content which might interest you:
Metabonomic analysis of exhaled breath condensate in adults by nuclear magnetic resonance spectroscopy
Source: Eur Respir J 2008; 32: 1175-1183
Year: 2008
Metabolomic signatures in nuclear magnetic resonance spectra of exhaled breath condensate identify asthma
Source: Eur Respir J 2012; 39: 500-502
Year: 2012
Methodological aspects of nuclear magnetic resonance spectroscopy of exhaled breath condensate
Source: Annual Congress 2011 - Bronchial hyperresponsiveness and exhaled and sputum biomarkers
Year: 2011
Nuclear magnetic resonance and mass spectrometry analysis of exhaled breath condensate
Source: Annual Congress 2009 - Noninvasive monitoring of airway inflammation: beyond exhaled nitric oxide
Year: 2009
Metabonomic approach for noninvasive diagnosis of inflammatory lung diseases through nuclear magnetic resonance analysis of exhaled breath condensate
Source: Annual Congress 2007 - Novel therapeutic targets and disease markers in pulmonary pathology
Year: 2007
Nuclear magnetic resonance-based metabolomics of exhaled breath condensate: methodological aspects
Source: Eur Respir J 2012; 39: 498-500
Year: 2012
Metabonomic analysis of EBC in adults by nuclear magnetic resonance spectroscopy
Source: Annual Congress 2008 - New frontiers in noninvasive assessment of the lungs
Year: 2008
NMR spectroscopy of exhaled breath condensate in the diagnosis of asthma: Validation and reproducibility
Source: Annual Congress 2010 - Exhaled biomarkers: smells like disease
Year: 2010
Detection of radicals by electron spin resonance (ESR) spectroscopy in exhaled breath condensate (EBC)
Source: Eur Respir J 2004; 24: Suppl. 48, 468s
Year: 2004
SELDI-TOF MS for proteomic analysis of exhaled breath condensate from patients with pulmonary emphysema
Source: Annual Congress 2009 - COPD: basic science and clinical studies
Year: 2009
129Xenon-enhanced magnetic resonance imaging to understand particle exhalation from the human lung
Source: International Congress 2018 – Biomarkers and lung function in airway disease
Year: 2018
Functional magnetic resonance imaging and lung function tests in cystic fibrosis
Source: International Congress 2017 – Cystic fibrosis: treatments and monitoring
Year: 2017
Patterns of regional lung physiology in cystic fibrosis using ventilation magnetic resonance imaging and multiple-breath washout
Source: Eur Respir J, 52 (5) 1800821; 10.1183/13993003.00821-2018
Year: 2018
Predicting multiple breath washout outcomes from hyperpolarised gas magnetic resonance imaging (MRI).
Source: International Congress 2019 – Imaging in respiratory disease: novel technologies in 2019
Year: 2019
Evaluation of the peripheral airway microstructure in children with cystic fibrosis (CF) using
3
He magnetic resonance imaging
Source: Annual Congress 2012 - Cystic fibrosis (adults and children): new therapies and detection of early lung disease
Year: 2012
Non-contrast-enhanced assessment of lung perfusion in CF patients during respiratory tract exacerbation using Fourier decomposition magnetic resonance imaging (FDMRI)
Source: Virtual Congress 2020 – Advances in cystic fibrosis: from microbiome to MRI
Year: 2020
Diagnosis of lung diseases based on proteomic analysis of exhaled breath condensate
Source: International Congress 2017 – Clinical problems in lung diseases
Year: 2017
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept